Compare PSNL & SUPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSNL | SUPV |
|---|---|---|
| Founded | 2011 | 1887 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.1M | 927.1M |
| IPO Year | 2019 | 2016 |
| Metric | PSNL | SUPV |
|---|---|---|
| Price | $9.19 | $10.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.71 | ★ $14.75 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 11-04-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $69,103,000.00 | ★ $467,987,272.00 |
| Revenue This Year | N/A | $20.86 |
| Revenue Next Year | $20.33 | $23.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.83 | $4.54 |
| 52 Week High | $11.40 | $19.75 |
| Indicator | PSNL | SUPV |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 53.45 |
| Support Level | $9.34 | $10.34 |
| Resistance Level | $9.85 | $12.13 |
| Average True Range (ATR) | 0.78 | 0.76 |
| MACD | -0.12 | -0.13 |
| Stochastic Oscillator | 31.13 | 57.09 |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.